Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease. An Individual Participant Meta-Analysis (Juraschek, JAMA 2023)
WIth no RCTs to go on, we review a meta-analysis on sodium thiosulphate for calciphylaxis
1/10
— Nephrology Journal Club (@NephJC) June 30, 2023
Welcome to #TenTweetNephJC
Calciphylaxis is a rare but grim complication of ESKD & everyone wants to throw the kitchen sink at treating it.
A key part of treatment is sodium thiosulphate - but does it work?
Catch up on #NephJC reviewing biggest meta-analysis to date🧵👇 pic.twitter.com/LpXU9NupUa
Vicki Sandys put together the visual abstract for this week’s NephJC
